Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Mechanism of O-GlcNAc Glycosylation Modified HAS2 in the Hyaluronic Acid Synthesis in ARDS

NCT05055557 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT05055557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Mechanism of O-GlcNAc Glycosylation Modified HAS2 in the Hyaluronic Acid Synthesis in ARDS
Lead sponsor
Southeast University, China
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2021
Completion date
September 30, 2022
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyaluronic acid